Clinical Trials · NCT05467033
Safety Outcomes Post Kidney Biopsy - Randomized Clinical Evaluation of Efficacy of Desmopressin
- Phase
- Phase 3
- Recruitment status
- Recruiting
- Sponsor
- Medical University of Bialystok
- Enrollment
- 424
- Start date
- Sep 2022
- Locations
- 1 site, Poland
- Primary endpoint
- Bleeding events in 24 hours after the procedure